These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 30819762)

  • 41. Beta
    Hostrup M; Reitelseder S; Jessen S; Kalsen A; Nyberg M; Egelund J; Kreiberg M; Kristensen CM; Thomassen M; Pilegaard H; Backer V; Jacobson GA; Holm L; Bangsbo J
    J Physiol; 2018 Sep; 596(17):4121-4139. PubMed ID: 29968301
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Low dose formoterol administration improves muscle function in dystrophic mdx mice without increasing fatigue.
    Harcourt LJ; Schertzer JD; Ryall JG; Lynch GS
    Neuromuscul Disord; 2007 Jan; 17(1):47-55. PubMed ID: 17134898
    [TBL] [Abstract][Full Text] [Related]  

  • 43. GW427353 (solabegron), a novel, selective beta3-adrenergic receptor agonist, evokes bladder relaxation and increases micturition reflex threshold in the dog.
    Hicks A; McCafferty GP; Riedel E; Aiyar N; Pullen M; Evans C; Luce TD; Coatney RW; Rivera GC; Westfall TD; Hieble JP
    J Pharmacol Exp Ther; 2007 Oct; 323(1):202-9. PubMed ID: 17626794
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Combinatory in vitro effects of the β2-agonists salbutamol and formoterol in skeletal muscle cells.
    Piribauer M; Jiang L; Kostov T; Parr M; Steidel S; Bizjak DA; Steinacker JM; Diel P
    Toxicol Lett; 2023 Apr; 378():10-18. PubMed ID: 36822333
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cell-based and in-silico studies on the high intrinsic activity of two boron-containing salbutamol derivatives at the human β₂-adrenoceptor.
    Soriano-Ursúa MA; McNaught-Flores DA; Nieto-Alamilla G; Segura-Cabrera A; Correa-Basurto J; Arias-Montaño JA; Trujillo-Ferrara JG
    Bioorg Med Chem; 2012 Jan; 20(2):933-41. PubMed ID: 22182578
    [TBL] [Abstract][Full Text] [Related]  

  • 46. β
    Shimamoto S; Ijiri D; Kawaguchi M; Nakashima K; Tada O; Inoue H; Ohtsuka A
    Comp Biochem Physiol A Mol Integr Physiol; 2017 Sep; 211():1-6. PubMed ID: 28578076
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Agonist-induced receptor internalization in Chinese hamster ovary cells stably co-expressing β(1)- and β(2)-adrenergic receptors.
    Yoshihara T; Yonoki Y; Saito M; Nakahara T; Sakamoto K; Ishii K
    Biol Pharm Bull; 2013; 36(1):114-9. PubMed ID: 23302644
    [TBL] [Abstract][Full Text] [Related]  

  • 48. beta-Adrenoceptor signaling in regenerating skeletal muscle after beta-agonist administration.
    Beitzel F; Sillence MN; Lynch GS
    Am J Physiol Endocrinol Metab; 2007 Oct; 293(4):E932-40. PubMed ID: 17623752
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacological basis for duration of effect: formoterol and salmeterol versus short-acting beta 2-adrenoceptor agonists.
    Lindén A; Rabe KF; Löfdahl CG
    Lung; 1996; 174(1):1-22. PubMed ID: 8746998
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Characterisation of the pharmacological profile of desoxymethyltestosterone (Madol), a steroid misused for doping.
    Diel P; Friedel A; Geyer H; Kamber M; Laudenbach-Leschowsky U; Schänzer W; Thevis M; Vollmer G; Zierau O
    Toxicol Lett; 2007 Feb; 169(1):64-71. PubMed ID: 17254722
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of masseter muscle β₂-adrenergic signaling in regulation of muscle activity, myosin heavy chain transition, and hypertrophy.
    Ohnuki Y; Umeki D; Cai W; Kawai N; Mototani Y; Shiozawa K; Jin HL; Fujita T; Tanaka E; Saeki Y; Okumura S
    J Pharmacol Sci; 2013 Sep; 123(1):36-46. PubMed ID: 23985574
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of β
    Vélez EJ; Balbuena-Pecino S; Capilla E; Navarro I; Gutiérrez J; Riera-Codina M
    Comp Biochem Physiol A Mol Integr Physiol; 2019 Jan; 227():179-193. PubMed ID: 30347245
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development of beta 3-adrenoceptor agonists for the treatment of obesity and diabetes--an update.
    Weyer C; Gautier JF; Danforth E
    Diabetes Metab; 1999 Mar; 25(1):11-21. PubMed ID: 10335419
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Beta2-adrenergic activation via administration of atenolol/formoterol combination increases contractility and coronary blood flow in isolated rat hearts.
    Watson DC; Sargianou M; Leivaditis V; Anagnostopoulos C
    Hellenic J Cardiol; 2013; 54(5):341-7. PubMed ID: 24100176
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of beta-adrenoceptor signaling in skeletal muscle: implications for muscle wasting and disease.
    Lynch GS; Ryall JG
    Physiol Rev; 2008 Apr; 88(2):729-67. PubMed ID: 18391178
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Classical and atypical binding sites for beta-adrenoceptor ligands and activation of adenylyl cyclase in bovine skeletal muscle and adipose tissue membranes.
    Sillence MN; Matthews ML
    Br J Pharmacol; 1994 Mar; 111(3):866-72. PubMed ID: 7912629
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cardiovascular effects of chronic treatment with a β2-adrenoceptor agonist relieving neuropathic pain in mice.
    Choucair-Jaafar N; Beetz N; Gilsbach R; Yalcin I; Waltisperger E; Freund-Mercier MJ; Monassier L; Hein L; Barrot M
    Neuropharmacology; 2011; 61(1-2):51-60. PubMed ID: 21352833
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of the beta
    Salazar-Degracia A; Busquets S; Argilés JM; Bargalló-Gispert N; López-Soriano FJ; Barreiro E
    Biochimie; 2018 Jun; 149():79-91. PubMed ID: 29654866
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Adrenoceptors and adaptive mechanisms in the heart during stress.
    Spadari-Bratfisch RC; dos Santos IN
    Ann N Y Acad Sci; 2008 Dec; 1148():377-83. PubMed ID: 19120131
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Formoterol decreases muscle wasting as well as inflammation in the rat model of rheumatoid arthritis.
    Gómez-SanMiguel AB; Gomez-Moreira C; Nieto-Bona MP; Fernández-Galaz C; Villanúa MÁ; Martín AI; López-Calderón A
    Am J Physiol Endocrinol Metab; 2016 Jun; 310(11):E925-37. PubMed ID: 27245339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.